Validating meropenem forecasts for the next dose during CRRT
Antimicrobial Agents and Chemotherapy · 10.11.2026
DOI: 10.1128/aac.01271-26 ↗Kurz gefasst
Leserbrief in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 10.11.2026. Verfasst von Yu Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Zitieren
APA
Jiang, Y., Chen, R., & Li, P. (2026). Validating meropenem forecasts for the next dose during CRRT. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01271-26
Vancouver
Jiang Y, Chen R, Li P. Validating meropenem forecasts for the next dose during CRRT. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01271-26
BibTeX
@article{Jiang2026,
author = {Jiang, Yu and Chen, Ruisi and Li, Peng},
title = {Validating meropenem forecasts for the next dose during CRRT},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.01271-26}
}
EUVIMED